Global COVID-19 Drugs Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 29-Apr-2020
No. of pages: 128
Inquire Before Buying

This report focuses on the global COVID-19 Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the COVID-19 Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

- Sanofi

- Novartis

- Shanghai Zhongxisanwei

- Teva

- Zydus Cadila

- Mylan

- Apotex

- Advanz Pharma

- Sun Pharma

- Kyung Poong

- Ipca Laboratories

- Hanlim Pharmaceutical

- Bristol Laboratories

- Bayer

- Rising Pharmaceutical

- Shanghai Pharma

- Sichuan Sunny Hope

- Guangzhou Baiyunshan Guanghua Pharmaceutical

- CSPC Group

- KPC Group

- Jinghua Pharmaceutical Group

- Zhongsheng Pharma

- North China Pharmaceutical Group

Market segment by Type, the product can be split into

- Tablet

- Injection

Market segment by Application, split into

- Mild Symptom Patient

- Critically Ill Patient

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global COVID-19 Drugs status, future forecast, growth opportunity, key market and key players.

- To present the COVID-19 Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of COVID-19 Drugs are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global COVID-19 Drugs Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by COVID-19 Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global COVID-19 Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Tablet
1.4.3 Injection
1.5 Market by Application
1.5.1 Global COVID-19 Drugs Market Share by Application: 2020 VS 2026
1.5.2 Mild Symptom Patient
1.5.3 Critically Ill Patient
1.6 Coronavirus Disease 2019 (Covid-19): COVID-19 Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the COVID-19 Drugs Industry
1.6.1.1 COVID-19 Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and COVID-19 Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for COVID-19 Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 COVID-19 Drugs Market Perspective (2015-2026)
2.2 COVID-19 Drugs Growth Trends by Regions
2.2.1 COVID-19 Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 COVID-19 Drugs Historic Market Share by Regions (2018-2019)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Competition Landscape by Key Players
3.1 COVID-19 Drugs Revenue by Players (2019-2020)
3.2 COVID-19 Drugs Key Players Head office and Area Served
3.3 Key Players COVID-19 Drugs Product/Solution/Service
3.4 Date of Enter into COVID-19 Drugs Market
3.5 Key Players COVID-19 Drugs Funding/Investment Analysis
3.6 Global Key Players COVID-19 Drugs Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans
4 Global COVID-19 Drugs Market Size by Type (2019-2026)
5 Global COVID-19 Drugs Market Size by Application (2019-2026)
6 North America
6.1 North America COVID-19 Drugs Market Forecast (2019-2026)
6.2 COVID-19 Drugs Key Players in North America (2019-2020)
6.3 North America COVID-19 Drugs Market Size by Type (2015-2020)
6.4 North America COVID-19 Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe COVID-19 Drugs Market Forecast (2019-2026)
7.2 COVID-19 Drugs Key Players in Europe (2019-2020)
7.3 Europe COVID-19 Drugs Market Size by Type (2015-2020)
7.4 Europe COVID-19 Drugs Market Size by Application (2015-2020)
8 China
8.1 China COVID-19 Drugs Market Forecast (2019-2026)
8.2 COVID-19 Drugs Key Players in China (2019-2020)
8.3 China COVID-19 Drugs Market Size by Type (2015-2020)
8.4 China COVID-19 Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan COVID-19 Drugs Market Forecast (2019-2026)
9.2 COVID-19 Drugs Key Players in Japan (2019-2020)
9.3 Japan COVID-19 Drugs Market Size by Type (2015-2020)
9.4 Japan COVID-19 Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia COVID-19 Drugs Market Forecast (2019-2026)
10.2 COVID-19 Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia COVID-19 Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia COVID-19 Drugs Market Size by Application (2015-2020)
11 India
11.1 India COVID-19 Drugs Market Forecast (2019-2026)
11.2 COVID-19 Drugs Key Players in India (2019-2020)
11.3 India COVID-19 Drugs Market Size by Type (2015-2020)
11.4 India COVID-19 Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America COVID-19 Drugs Market Forecast (2019-2026)
12.2 COVID-19 Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America COVID-19 Drugs Market Size by Type (2015-2020)
12.4 Central & South America COVID-19 Drugs Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview and Its Total Revenue
13.1.3 Sanofi COVID-19 Drugs Introduction
13.1.4 Sanofi Revenue in COVID-19 Drugs Business (2019-2020))
13.1.5 Sanofi Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview and Its Total Revenue
13.2.3 Novartis COVID-19 Drugs Introduction
13.2.4 Novartis Revenue in COVID-19 Drugs Business (2019-2020))
13.2.5 Novartis Recent Development
13.3 Shanghai Zhongxisanwei
13.3.1 Shanghai Zhongxisanwei Company Details
13.3.2 Shanghai Zhongxisanwei Business Overview and Its Total Revenue
13.3.3 Shanghai Zhongxisanwei COVID-19 Drugs Introduction
13.3.4 Shanghai Zhongxisanwei Revenue in COVID-19 Drugs Business (2019-2020))
13.3.5 Shanghai Zhongxisanwei Recent Development
13.4 Teva
13.4.1 Teva Company Details
13.4.2 Teva Business Overview and Its Total Revenue
13.4.3 Teva COVID-19 Drugs Introduction
13.4.4 Teva Revenue in COVID-19 Drugs Business (2019-2020))
13.4.5 Teva Recent Development
13.5 Zydus Cadila
13.5.1 Zydus Cadila Company Details
13.5.2 Zydus Cadila Business Overview and Its Total Revenue
13.5.3 Zydus Cadila COVID-19 Drugs Introduction
13.5.4 Zydus Cadila Revenue in COVID-19 Drugs Business (2019-2020))
13.5.5 Zydus Cadila Recent Development
13.6 Mylan
13.6.1 Mylan Company Details
13.6.2 Mylan Business Overview and Its Total Revenue
13.6.3 Mylan COVID-19 Drugs Introduction
13.6.4 Mylan Revenue in COVID-19 Drugs Business (2019-2020))
13.6.5 Mylan Recent Development
13.7 Apotex
13.7.1 Apotex Company Details
13.7.2 Apotex Business Overview and Its Total Revenue
13.7.3 Apotex COVID-19 Drugs Introduction
13.7.4 Apotex Revenue in COVID-19 Drugs Business (2019-2020))
13.7.5 Apotex Recent Development
13.8 Advanz Pharma
13.8.1 Advanz Pharma Company Details
13.8.2 Advanz Pharma Business Overview and Its Total Revenue
13.8.3 Advanz Pharma COVID-19 Drugs Introduction
13.8.4 Advanz Pharma Revenue in COVID-19 Drugs Business (2019-2020))
13.8.5 Advanz Pharma Recent Development
13.9 Sun Pharma
13.9.1 Sun Pharma Company Details
13.9.2 Sun Pharma Business Overview and Its Total Revenue
13.9.3 Sun Pharma COVID-19 Drugs Introduction
13.9.4 Sun Pharma Revenue in COVID-19 Drugs Business (2019-2020))
13.9.5 Sun Pharma Recent Development
13.10 Kyung Poong
13.10.1 Kyung Poong Company Details
13.10.2 Kyung Poong Business Overview and Its Total Revenue
13.10.3 Kyung Poong COVID-19 Drugs Introduction
13.10.4 Kyung Poong Revenue in COVID-19 Drugs Business (2019-2020))
13.10.5 Kyung Poong Recent Development
13.11 Ipca Laboratories
10.11.1 Ipca Laboratories Company Details
10.11.2 Ipca Laboratories Business Overview and Its Total Revenue
10.11.3 Ipca Laboratories COVID-19 Drugs Introduction
10.11.4 Ipca Laboratories Revenue in COVID-19 Drugs Business (2019-2020))
10.11.5 Ipca Laboratories Recent Development
13.12 Hanlim Pharmaceutical
10.12.1 Hanlim Pharmaceutical Company Details
10.12.2 Hanlim Pharmaceutical Business Overview and Its Total Revenue
10.12.3 Hanlim Pharmaceutical COVID-19 Drugs Introduction
10.12.4 Hanlim Pharmaceutical Revenue in COVID-19 Drugs Business (2019-2020))
10.12.5 Hanlim Pharmaceutical Recent Development
13.13 Bristol Laboratories
10.13.1 Bristol Laboratories Company Details
10.13.2 Bristol Laboratories Business Overview and Its Total Revenue
10.13.3 Bristol Laboratories COVID-19 Drugs Introduction
10.13.4 Bristol Laboratories Revenue in COVID-19 Drugs Business (2019-2020))
10.13.5 Bristol Laboratories Recent Development
13.14 Bayer
10.14.1 Bayer Company Details
10.14.2 Bayer Business Overview and Its Total Revenue
10.14.3 Bayer COVID-19 Drugs Introduction
10.14.4 Bayer Revenue in COVID-19 Drugs Business (2019-2020))
10.14.5 Bayer Recent Development
13.15 Rising Pharmaceutical
10.15.1 Rising Pharmaceutical Company Details
10.15.2 Rising Pharmaceutical Business Overview and Its Total Revenue
10.15.3 Rising Pharmaceutical COVID-19 Drugs Introduction
10.15.4 Rising Pharmaceutical Revenue in COVID-19 Drugs Business (2019-2020))
10.15.5 Rising Pharmaceutical Recent Development
13.16 Shanghai Pharma
10.16.1 Shanghai Pharma Company Details
10.16.2 Shanghai Pharma Business Overview and Its Total Revenue
10.16.3 Shanghai Pharma COVID-19 Drugs Introduction
10.16.4 Shanghai Pharma Revenue in COVID-19 Drugs Business (2019-2020))
10.16.5 Shanghai Pharma Recent Development
13.17 Sichuan Sunny Hope
10.17.1 Sichuan Sunny Hope Company Details
10.17.2 Sichuan Sunny Hope Business Overview and Its Total Revenue
10.17.3 Sichuan Sunny Hope COVID-19 Drugs Introduction
10.17.4 Sichuan Sunny Hope Revenue in COVID-19 Drugs Business (2019-2020))
10.17.5 Sichuan Sunny Hope Recent Development
13.18 Guangzhou Baiyunshan Guanghua Pharmaceutical
10.18.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details
10.18.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview and Its Total Revenue
10.18.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Introduction
10.18.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in COVID-19 Drugs Business (2019-2020))
10.18.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development
13.19 CSPC Group
10.19.1 CSPC Group Company Details
10.19.2 CSPC Group Business Overview and Its Total Revenue
10.19.3 CSPC Group COVID-19 Drugs Introduction
10.19.4 CSPC Group Revenue in COVID-19 Drugs Business (2019-2020))
10.19.5 CSPC Group Recent Development
13.20 KPC Group
10.20.1 KPC Group Company Details
10.20.2 KPC Group Business Overview and Its Total Revenue
10.20.3 KPC Group COVID-19 Drugs Introduction
10.20.4 KPC Group Revenue in COVID-19 Drugs Business (2019-2020))
10.20.5 KPC Group Recent Development
13.21 Jinghua Pharmaceutical Group
10.21.1 Jinghua Pharmaceutical Group Company Details
10.21.2 Jinghua Pharmaceutical Group Business Overview and Its Total Revenue
10.21.3 Jinghua Pharmaceutical Group COVID-19 Drugs Introduction
10.21.4 Jinghua Pharmaceutical Group Revenue in COVID-19 Drugs Business (2019-2020))
10.21.5 Jinghua Pharmaceutical Group Recent Development
13.22 Zhongsheng Pharma
10.22.1 Zhongsheng Pharma Company Details
10.22.2 Zhongsheng Pharma Business Overview and Its Total Revenue
10.22.3 Zhongsheng Pharma COVID-19 Drugs Introduction
10.22.4 Zhongsheng Pharma Revenue in COVID-19 Drugs Business (2019-2020))
10.22.5 Zhongsheng Pharma Recent Development
13.23 North China Pharmaceutical Group
10.23.1 North China Pharmaceutical Group Company Details
10.23.2 North China Pharmaceutical Group Business Overview and Its Total Revenue
10.23.3 North China Pharmaceutical Group COVID-19 Drugs Introduction
10.23.4 North China Pharmaceutical Group Revenue in COVID-19 Drugs Business (2019-2020))
10.23.5 North China Pharmaceutical Group Recent Development
14 Market Dynamics
14.1 Drivers
14.2 Challenges
14.3 Porter's Five Forces Analysis
14.4 Market Ecosystem and Value Chain Analysis
15 Key Findings in This Report
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. COVID-19 Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by COVID-19 Drugs Revenue
Table 3. Ranking of Global Top COVID-19 Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global COVID-19 Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tablet
Table 6. Key Players of Injection
Table 7. COVID-19 Impact Global Market: (Four COVID-19 Drugs Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for COVID-19 Drugs Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for COVID-19 Drugs Players to Combat Covid-19 Impact
Table 12. Global COVID-19 Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global COVID-19 Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global COVID-19 Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global COVID-19 Drugs Market Share by Regions 2019-2026
Table 16. Market Top Trends
Table 17. Market Use Cases
Table 18. Global COVID-19 Drugs Revenue by Players (2019-2020) (Million US$)
Table 19. Global COVID-19 Drugs Market Share by Players (2019-2020)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players COVID-19 Drugs Product Solution and Service
Table 22. Date of Enter into COVID-19 Drugs Market
Table 23. Global Key Players COVID-19 Drugs Funding/Investment Analysis (Million USD)
Table 24. Global Key Players COVID-19 Drugs Valuation & Market Capitalization (Million USD)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global COVID-19 Drugs Market Size by Type (2019-2026) (Million US$)
Table 27. Global COVID-19 Drugs Market Size Share by Type (2019-2026)
Table 28. Global COVID-19 Drugs Market Size by Application (2019-2026) (Million US$)
Table 29. Global COVID-19 Drugs Market Size Share by Application (2019-2026)
Table 30. North America Key Players COVID-19 Drugs Revenue (2019-2020) (Million US$)
Table 31. North America Key Players COVID-19 Drugs Market Share (2019-2020)
Table 32. North America COVID-19 Drugs Market Size by Type (2019-2026) (Million US$)
Table 33. North America COVID-19 Drugs Market Share by Type (2019-2026)
Table 34. North America COVID-19 Drugs Market Size by Application (2019-2026) (Million US$)
Table 35. North America COVID-19 Drugs Market Share by Application (2019-2026)
Table 36. Europe Key Players COVID-19 Drugs Revenue (2019-2020) (Million US$)
Table 37. Europe Key Players COVID-19 Drugs Market Share (2019-2020)
Table 38. Europe COVID-19 Drugs Market Size by Type (2019-2026) (Million US$)
Table 39. Europe COVID-19 Drugs Market Share by Type (2019-2026)
Table 40. Europe COVID-19 Drugs Market Size by Application (2019-2026) (Million US$)
Table 41. Europe COVID-19 Drugs Market Share by Application (2019-2026)
Table 42. China Key Players COVID-19 Drugs Revenue (2019-2020) (Million US$)
Table 43. China Key Players COVID-19 Drugs Market Share (2019-2020)
Table 44. China COVID-19 Drugs Market Size by Type (2019-2026) (Million US$)
Table 45. China COVID-19 Drugs Market Share by Type (2019-2026)
Table 46. China COVID-19 Drugs Market Size by Application (2019-2026) (Million US$)
Table 47. China COVID-19 Drugs Market Share by Application (2019-2026)
Table 48. Japan Key Players COVID-19 Drugs Revenue (2019-2020) (Million US$)
Table 49. Japan Key Players COVID-19 Drugs Market Share (2019-2020)
Table 50. Japan COVID-19 Drugs Market Size by Type (2019-2026) (Million US$)
Table 51. Japan COVID-19 Drugs Market Share by Type (2019-2026)
Table 52. Japan COVID-19 Drugs Market Size by Application (2019-2026) (Million US$)
Table 53. Japan COVID-19 Drugs Market Share by Application (2019-2026)
Table 54. Southeast Asia Key Players COVID-19 Drugs Revenue (2019-2020) (Million US$)
Table 55. Southeast Asia Key Players COVID-19 Drugs Market Share (2019-2020)
Table 56. Southeast Asia COVID-19 Drugs Market Size by Type (2019-2026) (Million US$)
Table 57. Southeast Asia COVID-19 Drugs Market Share by Type (2019-2026)
Table 58. Southeast Asia COVID-19 Drugs Market Size by Application (2019-2026) (Million US$)
Table 59. Southeast Asia COVID-19 Drugs Market Share by Application (2019-2026)
Table 60. India Key Players COVID-19 Drugs Revenue (2019-2020) (Million US$)
Table 61. India Key Players COVID-19 Drugs Market Share (2019-2020)
Table 62. India COVID-19 Drugs Market Size by Type (2019-2026) (Million US$)
Table 63. India COVID-19 Drugs Market Share by Type (2019-2026)
Table 64. India COVID-19 Drugs Market Size by Application (2019-2026) (Million US$)
Table 65. India COVID-19 Drugs Market Share by Application (2019-2026)
Table 66. Central & South America Key Players COVID-19 Drugs Revenue (2019-2020) (Million US$)
Table 67. Central & South America Key Players COVID-19 Drugs Market Share (2019-2020)
Table 68. Central & South America COVID-19 Drugs Market Size by Type (2019-2026) (Million US$)
Table 69. Central & South America COVID-19 Drugs Market Share by Type (2019-2026)
Table 70. Central & South America COVID-19 Drugs Market Size by Application (2019-2026) (Million US$)
Table 71. Central & South America COVID-19 Drugs Market Share by Application (2019-2026)
Table 72. Sanofi Company Details
Table 73. Sanofi Business Overview
Table 74. Sanofi Product
Table 75. Company Description and Business Overview
Table 76. Sanofi COVID-19 Drugs Product
Table 77. Sanofi Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 78. Sanofi Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Product
Table 82. Company Description and Business Overview
Table 83. Novartis COVID-19 Drugs Product
Table 84. Novartis Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 85. Novartis Recent Development
Table 86. Shanghai Zhongxisanwei Company Details
Table 87. Shanghai Zhongxisanwei Business Overview
Table 88. Shanghai Zhongxisanwei Product
Table 89. Company Description and Business Overview
Table 90. Shanghai Zhongxisanwei COVID-19 Drugs Product
Table 91. Shanghai Zhongxisanwei Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 92. Shanghai Zhongxisanwei Recent Development
Table 93. Teva Company Details
Table 94. Teva Business Overview
Table 95. Teva Product
Table 96. Company Description and Business Overview
Table 97. Teva COVID-19 Drugs Product
Table 98. Teva Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 99. Teva Recent Development
Table 100. Zydus Cadila Company Details
Table 101. Zydus Cadila Business Overview
Table 102. Zydus Cadila Product
Table 103. Company Description and Business Overview
Table 104. Zydus Cadila COVID-19 Drugs Product
Table 105. Zydus Cadila Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 106. Zydus Cadila Recent Development
Table 107. Mylan Company Details
Table 108. Mylan Business Overview
Table 109. Mylan Product
Table 110. Company Description and Business Overview
Table 111. Mylan COVID-19 Drugs Product
Table 112. Mylan Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 113. Mylan Recent Development
Table 114. Apotex Company Details
Table 115. Apotex Business Overview
Table 116. Apotex Product
Table 117. Company Description and Business Overview
Table 118. Apotex COVID-19 Drugs Product
Table 119. Apotex Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 120. Apotex Recent Development
Table 121. Advanz Pharma Business Overview
Table 122. Advanz Pharma Product
Table 123. Advanz Pharma Company Details
Table 124. Company Description and Business Overview
Table 125. Advanz Pharma COVID-19 Drugs Product
Table 126. Advanz Pharma Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 127. Advanz Pharma Recent Development
Table 128. Sun Pharma Company Details
Table 129. Sun Pharma Business Overview
Table 130. Sun Pharma Product
Table 131. Company Description and Business Overview
Table 132. Sun Pharma COVID-19 Drugs Product
Table 133. Sun Pharma Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 134. Sun Pharma Recent Development
Table 135. Kyung Poong Company Details
Table 136. Kyung Poong Business Overview
Table 137. Kyung Poong Product
Table 138. Company Description and Business Overview
Table 139. Kyung Poong COVID-19 Drugs Product
Table 140. Kyung Poong Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 141. Kyung Poong Recent Development
Table 142. Ipca Laboratories Company Details
Table 143. Ipca Laboratories Business Overview
Table 144. Ipca Laboratories Product
Table 145. Company Description and Business Overview
Table 146. Ipca Laboratories COVID-19 Drugs Product
Table 147. Ipca Laboratories Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 148. Ipca Laboratories Recent Development
Table 149. Hanlim Pharmaceutical Company Details
Table 150. Hanlim Pharmaceutical Business Overview
Table 151. Hanlim Pharmaceutical Product
Table 152. Company Description and Business Overview
Table 153. Hanlim Pharmaceutical COVID-19 Drugs Product
Table 154. Hanlim Pharmaceutical Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 155. Hanlim Pharmaceutical Recent Development
Table 156. Bristol Laboratories Company Details
Table 157. Bristol Laboratories Business Overview
Table 158. Bristol Laboratories Product
Table 159. Company Description and Business Overview
Table 160. Bristol Laboratories COVID-19 Drugs Product
Table 161. Bristol Laboratories Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 162. Bristol Laboratories Recent Development
Table 163. Bayer Company Details
Table 164. Bayer Business Overview
Table 165. Bayer Product
Table 166. Company Description and Business Overview
Table 167. Bayer COVID-19 Drugs Product
Table 168. Bayer Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 169. Bayer Recent Development
Table 170. Rising Pharmaceutical Company Details
Table 171. Rising Pharmaceutical Business Overview
Table 172. Rising Pharmaceutical Product
Table 173. Company Description and Business Overview
Table 174. Rising Pharmaceutical COVID-19 Drugs Product
Table 175. Rising Pharmaceutical Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 176. Rising Pharmaceutical Recent Development
Table 177. Shanghai Pharma Company Details
Table 178. Shanghai Pharma Business Overview
Table 179. Shanghai Pharma Product
Table 180. Company Description and Business Overview
Table 181. Shanghai Pharma COVID-19 Drugs Product
Table 182. Shanghai Pharma Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 183. Shanghai Pharma Recent Development
Table 184. Sichuan Sunny Hope Company Details
Table 185. Sichuan Sunny Hope Business Overview
Table 186. Sichuan Sunny Hope Product
Table 187. Company Description and Business Overview
Table 188. Sichuan Sunny Hope COVID-19 Drugs Product
Table 189. Sichuan Sunny Hope Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 190. Sichuan Sunny Hope Recent Development
Table 191. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Details
Table 192. Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
Table 193. Guangzhou Baiyunshan Guanghua Pharmaceutical Product
Table 194. Company Description and Business Overview
Table 195. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Product
Table 196. Guangzhou Baiyunshan Guanghua Pharmaceutical Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 197. Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Development
Table 198. CSPC Group Company Details
Table 199. CSPC Group Business Overview
Table 200. CSPC Group Product
Table 201. Company Description and Business Overview
Table 202. CSPC Group COVID-19 Drugs Product
Table 203. CSPC Group Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 204. CSPC Group Recent Development
Table 205. KPC Group Company Details
Table 206. KPC Group Business Overview
Table 207. KPC Group Product
Table 208. Company Description and Business Overview
Table 209. KPC Group COVID-19 Drugs Product
Table 210. KPC Group Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 211. KPC Group Recent Development
Table 212. Jinghua Pharmaceutical Group Company Details
Table 213. Jinghua Pharmaceutical Group Business Overview
Table 214. Jinghua Pharmaceutical Group Product
Table 215. Company Description and Business Overview
Table 216. Jinghua Pharmaceutical Group COVID-19 Drugs Product
Table 217. Jinghua Pharmaceutical Group Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 218. Jinghua Pharmaceutical Group Recent Development
Table 219. Zhongsheng Pharma Company Details
Table 220. Zhongsheng Pharma Business Overview
Table 221. Zhongsheng Pharma Product
Table 222. Company Description and Business Overview
Table 223. Zhongsheng Pharma COVID-19 Drugs Product
Table 224. Zhongsheng Pharma Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 225. Zhongsheng Pharma Recent Development
Table 226. North China Pharmaceutical Group Company Details
Table 227. North China Pharmaceutical Group Business Overview
Table 228. North China Pharmaceutical Group Product
Table 229. Company Description and Business Overview
Table 230. North China Pharmaceutical Group COVID-19 Drugs Product
Table 231. North China Pharmaceutical Group Revenue in COVID-19 Drugs Business 2019 and 2020 (Million US$)
Table 232. North China Pharmaceutical Group Recent Development
Table 233. Company Description and Business Overview
Table 234. Company Description and Business Overview
Table 235. Company Description and Business Overview
Table 236. Company Description and Business Overview
Table 237. Company Description and Business Overview
Table 238. Company Description and Business Overview
Table 239. Company Description and Business Overview
Table 240. Company Description and Business Overview
Table 241. Company Description and Business Overview
Table 242. Company Description and Business Overview
Table 243. Company Description and Business Overview
Table 244. Company Description and Business Overview
Table 245. Company Description and Business Overview
Table 246. Company Description and Business Overview
Table 247. Company Description and Business Overview
Table 248. Company Description and Business Overview
Table 249. Company Description and Business Overview
Table 250. Key Drivers: Impact Analysis (2021-2026)
Table 251. Key Opportunities
Table 252. Key Challenges
Table 253. Research Programs/Design for This Report
Table 254. Key Data Information from Secondary Sources
Table 255. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Drugs Market Share by Type: 2020 VS 2026
Figure 2. Tablet Features
Figure 3. Injection Features
Figure 4. Global COVID-19 Drugs Market Share by Application: 2020 VS 2026
Figure 5. Mild Symptom Patient Case Studies
Figure 6. Critically Ill Patient Case Studies
Figure 7. COVID-19 Drugs Report Years Considered
Figure 8. Global COVID-19 Drugs and Growth Rate (2019-2026) (Million US$)
Figure 9. Global COVID-19 Drugs Market Share by Regions (2019-2026)
Figure 10. Global COVID-19 Drugs Market Share by Players in 2019
Figure 11. Global COVID-19 Drugs Market Size Market Share by Type (2019-2026)
Figure 12. Global COVID-19 Drugs Market Size Market Share by Application (2019-2026)
Figure 13. North America COVID-19 Drugs Market Size YoY Growth (2019-2026) (Million US$)
Figure 14. Europe COVID-19 Drugs Market Size YoY Growth (2019-2026) (Million US$)
Figure 15. China COVID-19 Drugs Market Size YoY Growth (2019-2026) (Million US$)
Figure 16. Japan COVID-19 Drugs Market Size YoY Growth (2019-2026) (Million US$)
Figure 17. Southeast Asia COVID-19 Drugs Market Size YoY Growth (2019-2026) (Million US$)
Figure 18. India COVID-19 Drugs Market Size YoY Growth (2019-2026) (Million US$)
Figure 19. Central & South America COVID-19 Drugs Market Size YoY Growth (2019-2026) (Million US$)
Figure 20. Bottom-up and Top-down Approaches for This Report
Figure 21. Data Triangulation
Figure 22. Key Executives Interviewed
  • Global Joint Pain Injections Market Forecast 2022-2030
    Published: 25-Nov-2021        Price: US 2500 Onwards        Pages: 206
    KEY FINDINGS The global joint pain injections market is anticipated to register a CAGR of 8.56% during the forecast years of 2022 to 2030. The market growth is attributable to key drivers such as the increased prevalence of bone and joint-related diseases across the geriatric population, the increasing number of sports injuries, and the rising incidence of musculoskeletal disorders. MARKET INSIGHTS Joint pain injections are medicinal fluids introduced......
  • North America Joint Pain Injections Market Forecast 2022-2030
    Published: 25-Nov-2021        Price: US 1250 Onwards        Pages: 159
    KEY FINDINGS The North America joint pain injections market is projected to grow with a CAGR of 8.69% during the forecasting years of 2022 to 2030. Some of the key factors propelling the market growth of the region include the increasing number of new product launches and approvals, as well as the surging demand for innovative therapeutic platforms for joint pain to enhance treatment outcomes. MARKET INSIGHTS The North America joint pain injections ma......
  • Europe Joint Pain Injections Market Forecast 2022-2030
    Published: 25-Nov-2021        Price: US 1250 Onwards        Pages: 155
    KEY FINDINGS The Europe joint pain injections market is projected to register a CAGR of 8.30% over the forecasting period of 2022 to 2030. The regional market's growth is attributable to key developments in manufacturing infrastructure and facilities, the increasing prevalence of orthopedic diseases, surging innovations by biopharmaceutical companies, and the rising pharmaceutical production. MARKET INSIGHTS The Europe joint pain injections market gro......
  • Asia-Pacific Joint Pain Injections Market Forecast 2022-2030
    Published: 25-Nov-2021        Price: US 1250 Onwards        Pages: 145
    KEY FINDINGS The Asia-Pacific joint pain injections market is estimated to register a CAGR of 8.84% over the forecast period of 2022 to 2030. The market growth is propelled by the increased healthcare expenditure, the rising focus of market players in the region, the availability of advanced technology, the growing prevalence of orthopedic diseases, and the surging elderly populace. MARKET INSIGHTS The Asia-Pacific joint pain injections market growth......
  • Global and United States Iopamidol Injection Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 131
    Iopamidol Injection market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Iopamidol Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Iopamidol......
  • China Mycophenolate Mofetil Market Report & Forecast 2021-2027
    Published: 16-Nov-2021        Price: US 3400 Onwards        Pages: 92
    China Mycophenolate Mofetil Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) China Mycophenolate Mofetil Market Segment Percentages, By Type, 2020 (%) - Capsule - Tablet - Injection China Mycophenolate Mofetil Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) China Mycophenolate Mofetil Market Segment Percentages, By Application, 2020 (%) - Heart Transplant - Liver Transplant - Kidney Transpl......
  • China Morphine Market Report & Forecast 2021-2027
    Published: 16-Nov-2021        Price: US 3400 Onwards        Pages: 91
    China Morphine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kiloton) China Morphine Market Segment Percentages, By Type, 2020 (%) - Oral Tablets - Injection - Capsule - Others China Morphine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kiloton) China Morphine Market Segment Percentages, By Application, 2020 (%) - Anesthesia - Cough Suppressant - Diarrhea Suppressant Competitor An......
  • China Loratadine API Market Report & Forecast 2021-2027
    Published: 15-Nov-2021        Price: US 3400 Onwards        Pages: 91
    China Loratadine API Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT) China Loratadine API Market Segment Percentages, By Type, 2020 (%) - USP Standards Grade - EP Standards Grade - Pharmaceutical Standards Grade - Others China Loratadine API Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT) China Loratadine API Market Segment Percentages, By Application, 2020 (%) - Loratadine Tablet - Loratadine C......
  • China Levofloxacin Market Report & Forecast 2021-2027
    Published: 15-Nov-2021        Price: US 3400 Onwards        Pages: 94
    China Levofloxacin Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) China Levofloxacin Market Segment Percentages, By Type, 2020 (%) - 250 mg - 500 mg - 750 mg China Levofloxacin Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) China Levofloxacin Market Segment Percentages, By Application, 2020 (%) - Pneumonia - Skin Infection - Kidney Infection - Bladder Infection - Others......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs